{"id":"https://genegraph.clinicalgenome.org/r/89d81d65-0329-4d73-87c9-e68701cbbf54v1.1","type":"EvidenceStrengthAssertion","dc:description":"*BBS5* was first reported in relation to autosomal recessive Bardet-Biedl syndrome (BBS) in 2004 (Li et al., PMID: 15137946). BBS is a rare genetically heterogeneous ciliopathy, characterized by rod-cone dystrophy, polydactyly, obesity, genital anomalies, renal anomalies, and intellectual disabilities. For the purposes of this gene curation, cases caused by biallelic variants in the *BBS5* gene have been curated under the broader disease term BBS5-related ciliopathy.\n\nThis curation includes five variants (one missense, two frameshift, and two disrupting splicing) that have been reported in four probands. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function.\n\nThis gene-disease relationship is also supported by animal models indicating that loss of the *BBS5* ortholog recapitulates human patient features such as obesity, aberrant glucose homeostasis, and retinal abnormalities (PMIDs: 24559376, 31506453, 33560420).\n\nIn summary, there is definitive evidence supporting the relationship between *BBS5* and autosomal recessive BBS5-related ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Retina GCEP on the meeting date December 7th, 2023 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/89d81d65-0329-4d73-87c9-e68701cbbf54","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2023-12-07T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2025-01-04T03:59:23.238Z","role":"Publisher"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0c44b60-e895-454c-ba84-f8df45a25746_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0c44b60-e895-454c-ba84-f8df45a25746","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31506453","rdfs:label":"P1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/5eb89804-1937-44f8-8e9c-ebe9ddf81ba1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152384.3(BBS5):c.543del (p.Phe181LeufsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645520013"}},{"id":"https://genegraph.clinicalgenome.org/r/e261887c-25fc-4459-9662-edab17a64e0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152384.3(BBS5):c.412C>T (p.Arg138Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349164655"}}],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/952560fc-f14c-44ea-8a8a-726dd3ad3b80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31506453","allele":{"id":"https://genegraph.clinicalgenome.org/r/5eb89804-1937-44f8-8e9c-ebe9ddf81ba1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/340b4cdc-a354-4e17-a69a-5d5051f594e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31506453","allele":{"id":"https://genegraph.clinicalgenome.org/r/e261887c-25fc-4459-9662-edab17a64e0e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/340b4cdc-a354-4e17-a69a-5d5051f594e2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/340b4cdc-a354-4e17-a69a-5d5051f594e2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/340b4cdc-a354-4e17-a69a-5d5051f594e2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Failed to rescue morpholino knockdown.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/952560fc-f14c-44ea-8a8a-726dd3ad3b80","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/952560fc-f14c-44ea-8a8a-726dd3ad3b80_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/53d5febb-74b5-4131-83c4-24dab206139f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53d5febb-74b5-4131-83c4-24dab206139f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30850397","rdfs:label":"PII1","allele":{"id":"https://genegraph.clinicalgenome.org/r/50a4c10e-a7dd-4b9e-a175-4d671c3a411e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152384.3(BBS5):c.208+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349161260"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"three primary features (obesity, hypogonadism, and retinal dystrophy) and two secondary features (speech delay and dental anomalies),","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7a501026-023e-4384-b428-a5c024624610_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30850397","allele":{"id":"https://genegraph.clinicalgenome.org/r/50a4c10e-a7dd-4b9e-a175-4d671c3a411e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7a501026-023e-4384-b428-a5c024624610","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a501026-023e-4384-b428-a5c024624610_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/aec66677-9f39-49d2-96aa-aa8c8ced77fb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aec66677-9f39-49d2-96aa-aa8c8ced77fb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16877420","rdfs:label":"57011P","allele":{"id":"https://genegraph.clinicalgenome.org/r/04030157-2038-4fe8-b585-aaa3a120a8f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152384.3(BBS5):c.123del (p.Gly42GlufsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA760524994"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"BBS was diagnosed on the basis of the established criterion that four primary features or three primary plus two secondary features are necessary to make the diagnosis","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/da18468c-582f-44db-98e7-f7111577453b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16877420","allele":{"id":"https://genegraph.clinicalgenome.org/r/04030157-2038-4fe8-b585-aaa3a120a8f1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/da18468c-582f-44db-98e7-f7111577453b","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da18468c-582f-44db-98e7-f7111577453b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c045ddbd-22be-4811-8222-3a6be640b812_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31506453","rdfs:label":"RTP23","family":{"id":"https://genegraph.clinicalgenome.org/r/c045ddbd-22be-4811-8222-3a6be640b812","type":"Family","rdfs:label":"RTP23","member":{"id":"https://genegraph.clinicalgenome.org/r/f0c44b60-e895-454c-ba84-f8df45a25746"}},"phenotypeFreeText":"retinal dystrophy; OB, obesity; PD, polydactyly; UA, urogenital anomalies; CI,\ncognitive impairment;","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f0c44b60-e895-454c-ba84-f8df45a25746"}},{"id":"https://genegraph.clinicalgenome.org/r/85e1c730-3616-41b6-b810-82b452d83c99_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15137946","rdfs:label":"NFB9","estimatedLodScore":1.35,"family":{"id":"https://genegraph.clinicalgenome.org/r/85e1c730-3616-41b6-b810-82b452d83c99","type":"Family","rdfs:label":"NFB9","member":{"id":"https://genegraph.clinicalgenome.org/r/ae31ddff-9f5c-4dce-bc02-3eec705ae83e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15137946","rdfs:label":"II6","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa3a66f9-98c4-4202-b764-eec02962e4e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152384.3(BBS5):c.522+3A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253783"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9d594d3-b13f-4c46-b5d1-427c4326a39b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15137946","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa3a66f9-98c4-4202-b764-eec02962e4e6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"obesity, brachydactyly and/or syndactyly, retinal dystrophy, and male hypogenitalism,","phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ae31ddff-9f5c-4dce-bc02-3eec705ae83e"},"publishedLodScore":5.6,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/ae31ddff-9f5c-4dce-bc02-3eec705ae83e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae31ddff-9f5c-4dce-bc02-3eec705ae83e"},{"id":"https://genegraph.clinicalgenome.org/r/e9d594d3-b13f-4c46-b5d1-427c4326a39b","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9d594d3-b13f-4c46-b5d1-427c4326a39b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e9d594d3-b13f-4c46-b5d1-427c4326a39b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RNA analysis","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdb1249e-ab95-4d34-a43f-1dbb09eb3d94_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/620f873b-ff7a-4aba-ae1d-b2a28f556b2c","type":"EvidenceLine","dc:description":"Multiple morpholino knockdown papers curated. Phenotypes not sufficiently resembling human.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c5cc3f8-180c-4f04-9788-03e5133a1824","type":"Finding","dc:description":"abnormal body axis/length, notochord and somite morphology; ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31506453","rdfs:label":"Morpholino knockdown","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c5b04e94-33b7-4f5b-8495-413c8743dd07","type":"EvidenceLine","dc:description":"Incomplete loss of function allele affecting specific tissues; partial phenotype overlap.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9325b596-b011-4074-aff1-c5456236e778","type":"Finding","dc:description":"Skeletal defect and obesity partially resemble human BBS5 patients: ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33560420","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/57009be0-0493-4e1d-a34c-9eed2f09baa6","type":"EvidenceLine","dc:description":"Multiple zebrafish model scored, downgraded score to avoid double counting.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c8a2301-50d4-45d4-922f-1b4deb0b4763","type":"Finding","dc:description":"Retinal layering defects, abnormal cardiac looping and dilated, cystic pronephric ducts with reduced cilia expression, and reduced renal function seen in the Morphants resemble human patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24559376","rdfs:label":"Morpholino knockdown","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Definitive","sequence":9673,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Jv3OyCknOGc","type":"GeneValidityProposition","disease":"obo:MONDO_1040047","gene":"hgnc:970","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bdb1249e-ab95-4d34-a43f-1dbb09eb3d94-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}